Tasker, S. (2018). Prevalence and risk factor analysis for feline haemoplasmas in cats from Northern Serbia, with molecular subtyping

Objectives The objectives of this study were to estimate the prevalence of feline haemoplasma infections in Northern Serbia, identify potential risk factors and perform molecular subtyping of feline immunodeficiency virus (FIV). Methods PCR analysis for feline haemoplasmas was performed on surplus EDTA blood samples from 373 cats from the Belgrade region, Serbia. An ELISA was used to determine the prevalence of feline leukaemia virus (FeLV) and FIV; PCR was performed on a subpopulation of these cats. FIV subtyping was performed using PCR. Results Within this population, 64/373 cats (17.2%) were infected with one or more haemoplasma species. Mycoplasma haemofelis was detected in 20/373 cats (5.4%), ‘Candidatus Mycoplasma haemominutum’ in 47/373 cats (12.6%) and ‘Candidatus Mycoplasma turicensis’ in 23/373 cats (6.2%). Coinfections were observed in 21/373 cats (5.6%). Based on ELISA serological retroviral testing, 4/310 cats (1.3%) were infected with FeLV, whereas 78/331 (23.6%) were infected with FIV. Multivariable analysis identified significant associations between haemoplasma infection and anaemia (anaemic/non-anaemic, odds ratio [OR] 2.7, 95% confidence interval [CI] 1.04–7.1; P = 0.041]), male gender (male/female, OR 4.5, 95% CI 2.22–9.03; P <0.0005), outdoor access (yes/no, OR 5.2, 95% CI 2.28–11.92; P <0.0005), non-pedigree breed (non-pedigree/pedigree, OR 5.5, 95% CI 1.24–24.84; P = 0.025) and FIV seropositive status (positive/negative, OR 2.4, 95% CI 1.21–4.83; P = 0.012). PCR analysis of the FIV ELISA-positive samples revealed clade D as being the most prevalent. Conclusions and relevance All three known species of feline haemoplasma were detected, confirming their presence in Serbia; ‘Candidatus Mycoplasma haemominutum’ was the most prevalent. We found a high prevalence of FIV-infected cats and FIV clade D was most prevalent. Accepted: 19 February 2018 1 Diagnostic Laboratories, Molecular Diagnostic Unit, Langford Vets and School of Veterinary School, University of Bristol, Langford, UK 2 Department of Pathophysiology, Faculty of Veterinary Medicine, Belgrade University, Belgrade, Serbia 3 Department for Equine, Small Animal, Poultry and Wild Animal Diseases, Faculty of Veterinary Medicine, Belgrade University, Belgrade, Serbia 4 Laboratory of Veterinary Clinical Pathology, College of Agronomy and Veterinary Medicine, University of Brasília, Campus Universitário Darcy Ribeiro, Brasília, Brazil 5 Department of Pathobiology and Population Sciences, Royal Veterinary College, Hawkshead Lane, Hatfield, UK 6IDEXX Laboratories, Inc., Kovr Dr. West Sacramento, CA, USA *Current address: IDEXX Laboratories Ltd, Wetherby, UK Corresponding author: Elpida Sarvani DVM, MRCVS, Diagnostic Laboratories, Langford Vets and Bristol Veterinary School, University of Bristol, Langford, BS40 5DU, UK Email: elsarvani@gmail.com 770037 JOR0010.1177/2055116918770037Journal of Feline Medicine and Surgery Open ReportsSarvani et al research-article2018